Cleared Traditional

K130282 - REMINGTON MEDICAL CENTREFIRE 22 BIOPSY INSTRUMENT (FDA 510(k) Clearance)

May 2013
Decision
97d
Days
Class 2
Risk

K130282 is an FDA 510(k) clearance for the REMINGTON MEDICAL CENTREFIRE 22 BIOPSY INSTRUMENT. This device is classified as a Instrument, Biopsy (Class II - Special Controls, product code KNW).

Submitted by Remington Medical, Inc. (Alpharetta, US). The FDA issued a Cleared decision on May 13, 2013, 97 days after receiving the submission on February 5, 2013.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1075.

Submission Details

510(k) Number K130282 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 2013
Decision Date May 13, 2013
Days to Decision 97 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KNW - Instrument, Biopsy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1075

Similar Devices - KNW Instrument, Biopsy

All 11
Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module
K260365 · Devicor Medical Products, Inc. · Mar 2026
ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit)
K252795 · Argon Medical Devices, Inc. · Feb 2026
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
K252681 · Bard Peripheral Vascular, Inc. · Dec 2025
Marquee™ Disposable Core Biopsy Instrument and Instrument Kit
K250032 · Bard Peripheral Vascular, Inc. · Jul 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K243945 · SurGenTec, LLC · Apr 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K240664 · SurGenTec, LLC · Aug 2024